COLLEEN JOHNSON: Open Payments
NPI 1942471164 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 5 companies in 2025. Trend: 2023 $557 · 2024 $440 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Novo Nordisk Inc | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Wegovy, SKYRIZI, RINVOQ, DUPIXENT, EOHILIA, ENTYVIO, XIFAXAN.
Industry payments across NY — which companies pay providers there.
